![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, February 16, 2022 11:44:13 AM
Feb. 16, 2022 8:37 AM ETTetra Bio-Pharma Inc. (TBPMF)By: Ravikash, SA News Editor
Tetra Bio-Pharma (OTCQB:TBPMF) announced the approval of a C$4.5M participative loan from the ministère de l'Économie et de l'Innovation under the BioMed Propulsion Program, managed by Investissement Québec.
The company said the funding will support the development of ARDS-003 for acute respiratory distress syndrome whether or not it is caused by COVID-19; as well as in patients with Sepsis.
This company noted that the transaction is conditional on the approval of all shareholders and will be subject to a vote at the General Meeting in May 2022 since it will require the transfer of its head office from Ontario to the province of Quebec and the approval of certain financial terms.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM